Investigation of oxidative stress in blood, brain, kidney, and liver after oxime antidote HI-6 application in a mouse experimental model

References

• Aas, P. (1996). In vitro effects of toxogonin, HI-6, and HLo-7 on the release of [3H]acetylcholine from peripheral cholinergic nerves in rat airway smooth muscle. Eur J Pharmacol 301:59–66.
   PubMed Web of Science ®Google Scholar
• Bajgar, J. (2004). Organophosphates/nerve agent poisoning: mechanism of action, diagnosis, prophylaxis, and treatment. Adv Clin Chem 38:151–216.
   PubMed Web of Science ®Google Scholar
• Bartosova, L., Kuca, K., Kunesova, G., Jun, D. (2006). The acute toxicity of acetylcholinesterase reactivators in mice in relation to their structure. Neurotox Res 9:291–296.
   PubMed Web of Science ®Google Scholar
• Buckley, N. A., Eddleston, M., Szinicz, L. (2005). Oximes for acute organophosphate pesticide poisoning. Cochrane Database Syst Rev 1: CD005085.
   Google Scholar
• Carlberg, I., Mannervik, B. (1975). Purification and characterization of the flavoenzyme glutathione reductase from rat liver. J Biol Chem 250:5475–5480.
   PubMed Web of Science ®Google Scholar
• Clement, J. G., Lockwood, P. A. (1982). HI-6, an oxime which is an effective antidote of soman poisoning: a structure activity study. Toxicol Appl Pharmacol 64:140–146.
   PubMed Web of Science ®Google Scholar
• DiMeo, S., Venditti, P. (2001). Mitochondria in exercise-induced oxidative stress. Biol Signals Recept 10:125–140.
   PubMedGoogle Scholar
• Gilron, I. (1993). The emergency drug release program: regulatory aspects of new drug access in Canada. CMAJ 148:1151–1153.
   PubMed Web of Science ®Google Scholar
• Haigh, J. R., Adler, M., Apland, J. P., Deshpande, S. S., Barham, C. B., Demond, P., et al. (2010). Protection by pyridostigmine bromide of marmoset hemi-diaphragm acetylchoilnesterase activity after soman exposure. Chem Biol Interact 187(1–3):416–420.
   PubMed Web of Science ®Google Scholar
• Jungermann, K., Gardemann, A., Beuers, U., Balle, C., Sannemann, J., Beckh, K., et al. (1987). Regulation of liver metabolism by the hepatic nerves. Adv Enzyme Regul 26:63–88.
   PubMedGoogle Scholar
• Kassa, J. (2002). Review of oximes in the antidotal treatment of poisoning by organophosphorus nerve agents. J Toxicol Clin Toxicol 40:803–816.
   PubMed Web of Science ®Google Scholar
• Kepner, L. A., Wolthuis, O. L. (1978). A comparison of the oximes HS-6 and HI-6 in the therapy of soman intoxication in rodents. Eur J Pharmacol 48:377–382.
   PubMed Web of Science ®Google Scholar
• Koplovitz, I., Menton, R., Matthews, C., Shultz, M., Nails, C., Kelly, S. (1995). Dose-response effects of atropine and HI-6 treatment of organophosphorus poisoning in guinea pigs. Drug Chem Toxicol 18:119–136.
   PubMed Web of Science ®Google Scholar
• Kuca, K., Bartosova, L., Jun, D., Patocka, J., Cabal, J., Kassa, J., et al. (2005). New quaternary pyridine aldoximes as casual antidotes against nerve agents intoxication. Biomed Pap Med Fac Univ Palacky Olomouc Czech Rep 149:75–82.
   PubMedGoogle Scholar
• Lundy, P. M., Raveh, L., Amitai, G. (2006). Development of the bisquaternary oxime, HI-6, toward clinical use in the treatment of organohosphate nerve agent poisoning. Toxicol Rev 25:231–243.
   PubMedGoogle Scholar
• Marrs, T. C. (1993). Organophosphate poisoning. Pharmacol Ther 58:51–66.
   PubMed Web of Science ®Google Scholar
• McDonough, J. H., Van Shura, K. E., LaMont, J. C., McMonagle, J. D., Shih, T. M. (2009). Comparison of the intramuscular, intranasal, or sublingual routes of midazolam administration for the control of soman induced seizures. Basic Clin Pharmacol Toxicol 104:27–34.
   PubMed Web of Science ®Google Scholar
• Milatovic, D., Gupta, R. C., Aschner, M. (2006). Anticholinesterase toxicity and oxidative stress. Sci World J 6:124–131.
   Google Scholar
• Pohanka, M., Bandouchova, H., Sobotka, J., Sedlackova, J., Soukupova, I., Pikula, J. (2009a). Comparison of ferric reducing antioxidant power and square wave voltammetry for assay of low molecular weight antioxidants in blood plasma: performance and comparison of methods. Sensors 9:9094–9103.
   PubMed Web of Science ®Google Scholar
• Pohanka, M., Jun, D., Kuca, K. (2007). Amperometric biosensor for evaluation of competitive cholinesterase inhibition by the reactivator, HI-6. Anal Lett 40:2351–2359.
   Web of Science ®Google Scholar
• Pohanka, M., Karasova, J. Z., Musilek, K., Kuca, K., Kassa, J. (2009b). Effect of five acetylcholinesterase reactivators on tabun-intoxicated rats: induction of oxidative stress versus reactivation efficacy. J Appl Toxicol 29:483–488.
   PubMed Web of Science ®Google Scholar
• Pohanka, M., Pavlis, O., Pikula, J., Treml, F., Kuca, K. (2010). Modulation of tularemia disease progress by the bisquaternary pyridinium oxime, HI-6. Acta Vet Brno 79:443–448.
   Web of Science ®Google Scholar
• Pryor, W. A., Stanley, J. P. (1975). Letter: a suggested mechanism for the production of malonaldehyde during the autooxidation of polyunsaturated fatty acids. Nonenzymatic production of prostaglandin endoperoxides during autoxidation. J Org Chem 40:3615–3617.
   PubMed Web of Science ®Google Scholar
• Rosas-Ballina, M., Goldstein, R. S., Gallowitsch-Puerta, M., Yang, L., Valdes-Ferrer, S. I., Patel, N. B., et al. (2009). The selective alpha7 agonist GTS21 attenuates cytokine production in human whole blood and human monocytes activated by ligands for TLR2, TLR3, TLR4, TLR9, and RAGE. Mol Med 15:195–202.
   PubMed Web of Science ®Google Scholar
• Sakurada, K., Matsubara, K., Shimizu, K., Shiono, H., Seto, Y., Tsuge, K., et al. (2003). Pralidoxime iodide (2-PAM) penetrates across the blood-brain barrier. Neurochem Res 28:1401–1407.
   PubMed Web of Science ®Google Scholar
• Sevelova, L., Kuca, K., Krejcova, G., Vachek, J. (2004). The therapeutic efficacy of oxime treatment in cyclosarin poisoned mice pretreated with a combination of pyridostigmine benzactyzine and trihexylphenidyl. J Appl Biomed 2:163–167.
   Google Scholar
• Skulachev, V. P., Antonenko, Y. N., Cherepanov, D. A., Chernyak, B. V., Izyuomov, D. S., Khailova, L. S., et al. (2010). Prevention of cardiolipin oxidation and fatty acid cycling as two antioxidant mechanisms of cationic derivatives of plastoquinone (SkQs). Biochim Biophys Acta 1797(6–7):878–889.
   PubMed Web of Science ®Google Scholar
• Soukup, O., Pohanka, M., Tobin, G., Jun, D., Fusek, J., Musilek, K., et al. (2008). The effect of HI-6 on cholinesterases and on the cholinergic system of the rat bladder. Neuroendocrinol Lett 29:759–762.
   PubMed Web of Science ®Google Scholar
• Szydlowska-Czerniak, A., Dianoczki, C., Recseg, K., Karlovits, G., Szlyk, E. (2008). Determination of antioxidant capacities of vegetable oils by ferric-ion spectrophotometric methods. Talanta 76:899–905.
   PubMed Web of Science ®Google Scholar
• Vrdoljak, A. L., Berend, S., Zeljezic, D., Piljac-Zegarac, J., Plestina, S., Kuca, K., et al. (2009). Irinotecan side effects relieved by the use of HI-6 oxime: in vivo experimental approach. Basic Clin Pharmacol Toxicol 105:401–409.
   PubMed Web of Science ®Google Scholar
• Yi, C. X., La Fleur, S. E., Fliers, E., Kalsbeek, A. (2010). The role of the autonomic liver innervation in the control of energy metabolism. Biochim Biophys Acta 1802:416–431.
   PubMed Web of Science ®Google Scholar
• Yin, H., Porter, N. A. (2005). New insights regarding the autoxidation of polyunsaturated fatty acids. Antiox Redox Signal 7:170–184.
   PubMed Web of Science ®Google Scholar
• Yiu, W. H., Mead, P. A., Mansfield, B. C., Chou, J. Y. (2010). Oxidative stress mediates nephropathy in type Ia glycogen storage disease. Lab Invest 90:620–629.
   PubMed Web of Science ®Google Scholar
• Zembron-Lacny, A., Slowinska-Lisowska, M., Ziemba, A. (2009). Integration of the thiol redox status with cytokine response to physical training in professional basketball players. Physiol Res 59:239–245.
   PubMed Web of Science ®Google Scholar